MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. Mediterr J Hematol Infect Dis 2023, 15 (1), e2023047. https://doi.org/10.4084/MJHID.2023.047.